NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

I get your point... that the common shares cited didn't change.

Additionally, in the Prospectus Supplement Summary, on the earlier October 16th fling, it cites that the base shares, as of October 16, 2019 numbered. 584,430,368; and that the number of common shares after the offering would number 594,873,094.

Yet on the second filing, the number of shares as of the October 25th filing (9 days later), is still the exact same number is was on October 16th of 584,430,368. And the number of common shares after the offering should number 587,935,520, not 594,873,094 PLUS 3.5 million more.

So... it's hard to argue the two weren't really one. We'll see how that was handled in the next 10q... about 12 days from now.

Whatever the case, we should note, for posterity, that the terms
(both for time frame and reduction of warrant price)
regarding the warrants were slightly different.

While the price per share was $0.21 for both filings, the first filing modified the terms of certain existing warrants, they exchanged previously issued warrants for an equivalent number ranging from and adding 6 to 18 months to the expiration date. The weighted price of those warrants was reduced from .05 cents. The second filing modified the terms of certain existing warrants, they exchanged previously issued warrants for an equivalent number adding 12 more months to the expiration date. The weighted price of those warrants was reduced from 1.5 to 2.5 cents.

1st filing
https://www.sec.gov/Archives/edgar/data/1072379/000110465919055013/tm1920518d1_424b5.htm
2nd filing
https://www.sec.gov/Archives/edgar/data/1072379/000110465919056954/tm1921272d2_424b5.htm